tiprankstipranks
Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Germany Market

Aldeyra Therapeutics (137) Income Statement

Compare
0 Followers

Aldeyra Therapeutics Income Statement

Last quarter (Q4 2024), Aldeyra Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Aldeyra Therapeutics's net income was $-15.81M. See Aldeyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -262.78K$ -258.71K$ -264.18K$ -56.22K
Operating Expenses
$ 60.12T$ 42.79M$ 62.68M$ 56.22M$ 34.67M
Depreciation and Amortization
$ 0.00$ 262.78K$ 258.71K$ 264.18K$ 56.22K
EBITDA
$ -60.12T$ -35.21M$ -60.07M$ -55.77M$ -36.07M
Operating Income
$ -60.12T$ -42.79M$ -62.68M$ -56.22M$ -36.42M
Other Income/Expenses
$ 4.27T$ 5.25M$ 655.35K$ -1.56M$ -3.37M
Pretax Income
$ -55.85T$ -37.54M$ -62.02M$ -57.78M$ -38.03M
Net Income
$ -55.85T$ -37.54M$ -61.37M$ -59.25M$ -37.55M
Per Share Metrics
Basic EPS
$ -938.92K$ -0.64$ -1.05$ -1.10$ -1.11
Diluted EPS
$ -938.92K$ -0.64$ -1.05$ -1.10$ -1.11
Weighted Average Shares Outstanding
59.48M 58.94M 58.41M 54.04M 33.97M
Weighted Average Shares Outstanding (Diluted)
59.48M 58.94M 58.41M 54.04M 33.97M
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis